HCPCS Level II code Q4116 denotes billing for Alloderm, an acellular dermal matrix product, billed per square centimeter as an add-on supply to a primary surgical procedure. This code matters nationally because implantable biologic supplies like Alloderm are commonly used in reconstructive and soft-tissue procedures and can materially affect episode costs and coverage determinations.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context and use cases, typical sites of service, and the payer landscape that influences coverage and payment. The publication summarizes benchmarks for utilization and reimbursement where available, highlights relevant policy considerations for add-on supply coding, and outlines common modifier usage patterns and billing practice implications. Data not available in the input is noted where applicable. The content is intended to help coding professionals, billing managers, and policy analysts understand HCPCS Level II code Q4116 and its role in surgical supply billing.